Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS investigators.

Gastroenterology. 2019 May 29. pii: S0016-5085(19)40974-8. doi: 10.1053/j.gastro.2019.05.056. [Epub ahead of print]

PMID:
31152740
2.

Pantoprazole to Prevents Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-blind, Placebo-controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko A, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS investigators.

Gastroenterology. 2019 May 2. pii: S0016-5085(19)36764-2. doi: 10.1053/j.gastro.2019.04.041. [Epub ahead of print]

PMID:
31054846
3.

Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.

Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC.

Gut. 2019 Apr 17. pii: gutjnl-2018-318160. doi: 10.1136/gutjnl-2018-318160. [Epub ahead of print]

PMID:
30996042
4.

Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2019 May;49(9):1254-1255. doi: 10.1111/apt.15234. No abstract available.

PMID:
30977174
5.

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.

Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P.

Gastroenterology. 2019 Mar 30. pii: S0016-5085(19)34649-9. doi: 10.1053/j.gastro.2019.03.049. [Epub ahead of print]

PMID:
30940523
6.

Clinical Practice Guideline for the Management of Luminal Crohn's Disease: The Toronto Consensus.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30253-8. doi: 10.1016/j.cgh.2019.02.043. [Epub ahead of print]

PMID:
30853616
7.

Response to Letter by Moulton et al.

Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, Moayyedi P.

Inflamm Bowel Dis. 2019 Mar 2. pii: izz035. doi: 10.1093/ibd/izz035. [Epub ahead of print] No abstract available.

PMID:
30824939
8.

Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease.

Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, Moayyedi P.

Inflamm Bowel Dis. 2019 Jan 7. doi: 10.1093/ibd/izy385. [Epub ahead of print]

PMID:
30615113
9.

Imipramine for functional dyspepsia: a 60-year journey.

Kanno T, Moayyedi P.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):815-817. doi: 10.1016/S2468-1253(18)30338-8. Epub 2018 Oct 22. No abstract available.

PMID:
30361079
10.

Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.

Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE, Andrews CN, Leontiadis GI, Moayyedi P.

Am J Gastroenterol. 2019 Feb;114(2):233-243. doi: 10.1038/s41395-018-0258-6.

PMID:
30337705
11.

Prokinetics for functional dyspepsia.

Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Leontiadis GI, Moayyedi P.

Cochrane Database Syst Rev. 2018 Oct 18;10:CD009431. doi: 10.1002/14651858.CD009431.pub3.

PMID:
30335201
12.

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2018 Nov;48(10):1044-1060. doi: 10.1111/apt.15001. Epub 2018 Oct 8. Review.

PMID:
30294792
13.

Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry.

Chen JH, Parsons SP, Shokrollahi M, Wan A, Vincent AD, Yuan Y, Pervez M, Chen WL, Xue M, Zhang KK, Eshtiaghi A, Armstrong D, Bercik P, Moayyedi P, Greenwald E, Ratcliffe EM, Huizinga JD.

Front Physiol. 2018 Sep 20;9:1248. doi: 10.3389/fphys.2018.01248. eCollection 2018.

14.

A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups.

Yongwen Ng J, Chauhan U, Armstrong D, Marshall J, Tse F, Moayyedi P, Reinisch W, Halder S.

Gastroenterol Nurs. 2018 Sep/Oct;41(5):427-435. doi: 10.1097/SGA.0000000000000338.

PMID:
30272605
15.

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2019 Jan;114(1):21-39. doi: 10.1038/s41395-018-0222-5.

16.

Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.

Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC.

Gastroenterology. 2018 Dec;155(6):1753-1763. doi: 10.1053/j.gastro.2018.08.021. Epub 2018 Aug 23.

PMID:
30144426
17.

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, Afif W, Bernstein CN, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C.

Inflamm Bowel Dis. 2019 Jan 1;25(1):1-13. doi: 10.1093/ibd/izy247.

PMID:
30099529
18.

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.

Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Brooks C, Attwood S, Harrison R, Barr H, Moayyedi P; AspECT Trial Team.

Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26. Erratum in: Lancet. 2018 Dec 15;392(10164):2552.

19.

A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.

Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2018 Sep;113(9):1290-1300. doi: 10.1038/s41395-018-0195-4. Epub 2018 Jul 26. Review.

20.

Proton pump inhibitors and gastric cancer: association is not causation.

Moayyedi P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, Jones N, Leontiadis GI.

Gut. 2018 Jul 13. pii: gutjnl-2018-316958. doi: 10.1136/gutjnl-2018-316958. [Epub ahead of print] No abstract available.

PMID:
30006494
21.

Update on Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Disease.

Moayyedi P.

Gastroenterol Hepatol (N Y). 2018 May;14(5):319-322. No abstract available.

22.

American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.

Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EMM; ACG Task Force on Management of Irritable Bowel Syndrome.

Am J Gastroenterol. 2018 Jun;113(Suppl 2):1-18. doi: 10.1038/s41395-018-0084-x. No abstract available.

23.

FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects.

Turpin W, Bedrani L, Espin-Garcia O, Xu W, Silverberg MS, Smith MI, Guttman DS, Griffiths A, Moayyedi P, Panaccione R, Huynh H, Steinhart H, Aumais G, Shestopaloff K, Dieleman LA, Turner D, Paterson AD, Croitoru K.

Gut Microbes. 2018 Jul 4;9(4):357-368. doi: 10.1080/19490976.2018.1445956. Epub 2018 Apr 27.

24.

Response to Marlicz et al.

Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2018 May;113(5):781. doi: 10.1038/s41395-018-0034-7. Epub 2018 Mar 9. No abstract available.

PMID:
29523865
25.

Reply.

Pinto Sanchez MI, Moayyedi P, Bercik P.

Gastroenterology. 2018 Feb;154(3):764-765. doi: 10.1053/j.gastro.2018.01.022. Epub 2018 Jan 17. No abstract available.

PMID:
29351832
26.

Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis.

Jarde A, Lewis-Mikhael AM, Moayyedi P, Stearns JC, Collins SM, Beyene J, McDonald SD.

BMC Pregnancy Childbirth. 2018 Jan 8;18(1):14. doi: 10.1186/s12884-017-1629-5. Review.

27.

Proton Pump Inhibitors and Dementia: Deciphering the Data.

Moayyedi P, Lewis MA.

Am J Gastroenterol. 2017 Dec;112(12):1809-1811. doi: 10.1038/ajg.2017.415.

PMID:
29215629
28.

Signature Celebration of Gastroenterology, Colorectal Cancer.

Chan AT, Moayyedi P.

Gastroenterology. 2018 Mar;154(4):767-770. doi: 10.1053/j.gastro.2017.11.029. Epub 2017 Nov 24. No abstract available.

PMID:
29174953
29.

Proton pump inhibitors for functional dyspepsia.

Pinto-Sanchez MI, Yuan Y, Hassan A, Bercik P, Moayyedi P.

Cochrane Database Syst Rev. 2017 Nov 21;11:CD011194. doi: 10.1002/14651858.CD011194.pub3. Review.

30.

Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, Emmanuel A, Hungin APS, Layer P, Stanghellini V, Whorwell P, Zerbib F, Tack J.

United European Gastroenterol J. 2017 Oct;5(6):773-788. doi: 10.1177/2050640617731968. Epub 2017 Sep 28. Review.

31.

Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.

Narula N, Kassam Z, Yuan Y, Colombel JF, Ponsioen C, Reinisch W, Moayyedi P.

Inflamm Bowel Dis. 2017 Oct;23(10):1702-1709. doi: 10.1097/MIB.0000000000001228. Review.

PMID:
28906291
32.
33.

Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia.

Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2017 Sep;112(9):1484. doi: 10.1038/ajg.2017.238. Epub 2017 Aug 1. No abstract available.

PMID:
28762378
34.

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, Bhatt DL, Branch KRH, Probstfield JL, Liang Y, Liu L, Zhu J, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Fox KAA, Kakkar A, Parkhomenko AN, Ertl G, Störk S, Keltai K, Keltai M, Ryden L, Dagenais GR, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Ha JW, Tonkin AM, Varigos JD, Lewis BS, Felix C, Yusoff K, Steg PG, Aboyans V, Metsarinne KP, Anand SS, Hart RG, Lamy A, Moayyedi P, Leong DP, Sharma M, Yusuf S.

Can J Cardiol. 2017 Aug;33(8):1027-1035. doi: 10.1016/j.cjca.2017.06.001. Epub 2017 Jun 8. Review.

35.

ACG and CAG Clinical Guideline: Management of Dyspepsia.

Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2017 Jul;112(7):988-1013. doi: 10.1038/ajg.2017.154. Epub 2017 Jun 20. Review. Erratum in: Am J Gastroenterol. 2017 Sep;112(9):1484.

PMID:
28631728
36.

White Paper AGA: Functional Dyspepsia.

Vakil NB, Howden CW, Moayyedi P, Tack J.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1191-1194. doi: 10.1016/j.cgh.2017.05.013. Epub 2017 May 18.

PMID:
28529164
37.

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P.

Can Fam Physician. 2017 May;63(5):354-364.

38.

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.

Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P.

Gastroenterology. 2017 Aug;153(2):448-459.e8. doi: 10.1053/j.gastro.2017.05.003. Epub 2017 May 5.

39.

Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies.

Pinto-Sánchez MI, Causada-Calo N, Bercik P, Ford AC, Murray JA, Armstrong D, Semrad C, Kupfer SS, Alaedini A, Moayyedi P, Leffler DA, Verdú EF, Green P.

Gastroenterology. 2017 Aug;153(2):395-409.e3. doi: 10.1053/j.gastro.2017.04.009. Epub 2017 Apr 18. Review.

40.

Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' reply.

Sood R, Gracie DJ, Gold MJ, To N, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC, Law GR.

Aliment Pharmacol Ther. 2017 May;45(9):1268-1269. doi: 10.1111/apt.14012. No abstract available.

41.

Letter: NICE referral criteria for lower gastrointestinal alarm features - not ideal but not poor either. Authors' reply.

Simpkins SJ, Pintos-Sanchez MI, Moayyedi P, Bercik P, Morgan DG, Bolino C, Ford AC.

Aliment Pharmacol Ther. 2017 Apr;45(8):1176. doi: 10.1111/apt.13996. No abstract available.

42.

Deprescribing versus continuation of chronic proton pump inhibitor use in adults.

Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, Pottie K, Farrell B.

Cochrane Database Syst Rev. 2017 Mar 16;3:CD011969. doi: 10.1002/14651858.CD011969.pub2. Review.

43.

Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial.

Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ.

Am J Gastroenterol. 2017 Jun;112(6):903-909. doi: 10.1038/ajg.2017.52. Epub 2017 Mar 14.

PMID:
28291238
44.

Proton pump inhibitors for functional dyspepsia.

Pinto-Sanchez MI, Yuan Y, Bercik P, Moayyedi P.

Cochrane Database Syst Rev. 2017 Mar 8;3:CD011194. doi: 10.1002/14651858.CD011194.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Nov 21;11:CD011194.

45.

Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 2.

Moayyedi P, Jaeschke R.

Pol Arch Intern Med. 2017 Feb 28;127(2):137-138. doi: 10.20452/pamw.3963. Epub 2017 Feb 28. No abstract available.

46.

Microbiome: the beginning of understanding. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 1.

Moayyedi P, Jaeschke R.

Pol Arch Intern Med. 2017 Feb 28;127(2):135-136. doi: 10.20452/pamw.3961. Epub 2017 Feb 28. No abstract available.

47.

The gut microbiota and psychiatric illness.

MacQueen G, Surette M, Moayyedi P.

J Psychiatry Neurosci. 2017 Mar;42(2):75-77. No abstract available.

48.

Optimal strategies for pancreatic cyst surveillance: we need better comparative data, not more case series.

Vege SS, Ziring B, Jain R, Scheiman JM, Hwang JH, Moayyedi P.

Gastrointest Endosc. 2017 Mar;85(3):685-686. doi: 10.1016/j.gie.2016.09.007. No abstract available.

PMID:
28215775
49.

Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.

Sood R, Gracie DJ, Gold MJ, To N, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC, Law GR.

Aliment Pharmacol Ther. 2017 Mar;45(6):824-832. doi: 10.1111/apt.13949. Epub 2017 Jan 20.

50.

American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease.

Herrine SK, Moayyedi P, Brown RS Jr, Falck-Ytter YT.

Gastroenterology. 2017 Feb;152(3):648-664.e5. doi: 10.1053/j.gastro.2016.12.027. Epub 2017 Jan 4. No abstract available.

PMID:
28061338

Supplemental Content

Loading ...
Support Center